Use of complementary and alternative medicine in patients with chronic viral hepatitis in Turkey

Basit Öğe Kaydı
dc.authoridYildiz, Ilknur Esen/0000-0003-2987-0483
dc.authorwosidInce, Nevin/O-5890-2016
dc.authorwosidYildiz, Ilknur Esen/AAR-3407-2021
dc.contributor.authorInce, Nevin
dc.contributor.authorKaya, Safak
dc.contributor.authorYildiz, Ilknur Esen
dc.contributor.authorParlak, Emine
dc.contributor.authorBayar, Belkis
dc.date.accessioned2021-12-01T18:50:07Z
dc.date.available2021-12-01T18:50:07Z
dc.date.issued2020
dc.department[Belirlenecek]en_US
dc.description.abstractIntroduction: The global use of complementary and alternative medicine (CAM) is growing. The purpose of this study was to determine the prevalence of CAM use in patients in Turkey with CVH, the types of therapy, and patients' sociodemographic characteristics. Methods: The study was designed as a questionnaire-based, cross-sectional analysis. An infectious diseases outpatient follow-up questionnaire was administered to patients at face-to-face interviews. The data obtained were analyzed using SPSS 17 software. Results: This study included 588 patients, of whom 27% used CAM. No differences in sociodemographic characteristics were determined between patients using CAM and those not using it. Herbal methods were used by 63.6% of patients and cupping techniques by 25.4%. Education level was significantly correlated with herbal methods (p = 0.043). CAM use also increased in line with disease duration (p < 0.05). No difference in CAM use was determined between CHB patients using oral antiviral therapy and those not using it (p = 0.162). Conclusion: CAM use, particularly herbal products, is prevalent among Turkish adults with CVH. In case of use of herbal products in chronic viral hepatitis patients, toxicity and liver failure may develop as a result of herbal product-drug interactions. Physicians in the field of hepatology should, therefore, be aware of potential toxicity of CAM, especially in patients with chronic hepatitis liver diseases.en_US
dc.identifier.doi10.1016/j.ctim.2019.102229
dc.identifier.issn0965-2299
dc.identifier.issn1873-6963
dc.identifier.pmid31987221en_US
dc.identifier.scopus2-s2.0-85074683275en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.1016/j.ctim.2019.102229
dc.identifier.urihttps://hdl.handle.net/20.500.12684/10830
dc.identifier.volume48en_US
dc.identifier.wosWOS:000514023100014en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherChurchill Livingstoneen_US
dc.relation.ispartofComplementary Therapies In Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectChronic viral hepatitisen_US
dc.subjectComplemantary and Alternative Medicineen_US
dc.subjectPrevalenceen_US
dc.subjectAttitudeen_US
dc.subjectTurkeyen_US
dc.subjectUnited-Statesen_US
dc.subjectPrevalenceen_US
dc.subjectInfectionen_US
dc.subjectAdultsen_US
dc.subjectTrendsen_US
dc.titleUse of complementary and alternative medicine in patients with chronic viral hepatitis in Turkeyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
10830.pdf
Boyut:
205.08 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu